nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—breast cancer	0.408	0.63	CbGaD
Ephedrine—BCHE—breast cancer	0.24	0.37	CbGaD
Ephedrine—ACHE—Irinotecan—breast cancer	0.0693	0.624	CbGbCtD
Ephedrine—BCHE—Irinotecan—breast cancer	0.0418	0.376	CbGbCtD
Ephedrine—Etomidate—SLC2A1—breast cancer	0.00198	0.435	CrCbGaD
Ephedrine—Pseudoephedrine—IL2—breast cancer	0.000615	0.135	CrCbGaD
Ephedrine—SLC18A2—endometrium—breast cancer	0.000474	0.0634	CbGeAlD
Ephedrine—SLC18A2—uterus—breast cancer	0.000437	0.0585	CbGeAlD
Ephedrine—SLC18A2—adipose tissue—breast cancer	0.000428	0.0572	CbGeAlD
Ephedrine—BCHE—nipple—breast cancer	0.000396	0.053	CbGeAlD
Ephedrine—ACHE—adrenal gland—breast cancer	0.000394	0.0526	CbGeAlD
Ephedrine—SLC18A2—female reproductive system—breast cancer	0.000393	0.0525	CbGeAlD
Ephedrine—SLC18A2—adrenal gland—breast cancer	0.000384	0.0513	CbGeAlD
Ephedrine—Etomidate—CYP19A1—breast cancer	0.000373	0.0819	CrCbGaD
Ephedrine—SLC18A2—endocrine gland—breast cancer	0.000333	0.0445	CbGeAlD
Ephedrine—ADRA1A—epithelium—breast cancer	0.0003	0.0401	CbGeAlD
Ephedrine—BCHE—skin of body—breast cancer	0.000254	0.0339	CbGeAlD
Ephedrine—ADRA1A—adipose tissue—breast cancer	0.000243	0.0324	CbGeAlD
Ephedrine—SLC6A2—female reproductive system—breast cancer	0.00024	0.0321	CbGeAlD
Ephedrine—BCHE—endometrium—breast cancer	0.000239	0.032	CbGeAlD
Ephedrine—ACHE—lymph node—breast cancer	0.000236	0.0315	CbGeAlD
Ephedrine—SLC6A2—adrenal gland—breast cancer	0.000234	0.0313	CbGeAlD
Ephedrine—SLC18A2—lymph node—breast cancer	0.00023	0.0307	CbGeAlD
Ephedrine—BCHE—uterus—breast cancer	0.00022	0.0295	CbGeAlD
Ephedrine—ADRA1A—adrenal gland—breast cancer	0.000218	0.0291	CbGeAlD
Ephedrine—BCHE—pituitary gland—breast cancer	0.000217	0.029	CbGeAlD
Ephedrine—BCHE—adipose tissue—breast cancer	0.000216	0.0288	CbGeAlD
Ephedrine—Pseudoephedrine—TNF—breast cancer	0.000207	0.0455	CrCbGaD
Ephedrine—SLC6A2—endocrine gland—breast cancer	0.000203	0.0271	CbGeAlD
Ephedrine—BCHE—female reproductive system—breast cancer	0.000198	0.0265	CbGeAlD
Ephedrine—BCHE—adrenal gland—breast cancer	0.000193	0.0259	CbGeAlD
Ephedrine—ADRA1A—endocrine gland—breast cancer	0.000189	0.0252	CbGeAlD
Ephedrine—BCHE—bone marrow—breast cancer	0.000187	0.025	CbGeAlD
Ephedrine—Anorexia—Irinotecan—breast cancer	0.00018	0.00123	CcSEcCtD
Ephedrine—Anorexia—Mitoxantrone—breast cancer	0.00018	0.00123	CcSEcCtD
Ephedrine—Nausea—Chlorambucil—breast cancer	0.000179	0.00122	CcSEcCtD
Ephedrine—Hyperhidrosis—Gemcitabine—breast cancer	0.000178	0.00122	CcSEcCtD
Ephedrine—Dizziness—Tamoxifen—breast cancer	0.000177	0.00121	CcSEcCtD
Ephedrine—Tremor—Paclitaxel—breast cancer	0.000177	0.00121	CcSEcCtD
Ephedrine—Tachycardia—Fluorouracil—breast cancer	0.000176	0.00121	CcSEcCtD
Ephedrine—Anorexia—Gemcitabine—breast cancer	0.000175	0.0012	CcSEcCtD
Ephedrine—Vomiting—Vinblastine—breast cancer	0.000175	0.0012	CcSEcCtD
Ephedrine—Agitation—Paclitaxel—breast cancer	0.000173	0.00119	CcSEcCtD
Ephedrine—Body temperature increased—Thiotepa—breast cancer	0.000173	0.00119	CcSEcCtD
Ephedrine—Headache—Vinblastine—breast cancer	0.000173	0.00118	CcSEcCtD
Ephedrine—Anorexia—Fluorouracil—breast cancer	0.000172	0.00118	CcSEcCtD
Ephedrine—Insomnia—Irinotecan—breast cancer	0.000171	0.00117	CcSEcCtD
Ephedrine—Vomiting—Tamoxifen—breast cancer	0.00017	0.00117	CcSEcCtD
Ephedrine—Vertigo—Paclitaxel—breast cancer	0.000169	0.00116	CcSEcCtD
Ephedrine—Dizziness—Goserelin—breast cancer	0.000169	0.00116	CcSEcCtD
Ephedrine—Rash—Tamoxifen—breast cancer	0.000169	0.00116	CcSEcCtD
Ephedrine—Dermatitis—Tamoxifen—breast cancer	0.000169	0.00116	CcSEcCtD
Ephedrine—Dyspnoea—Irinotecan—breast cancer	0.000168	0.00115	CcSEcCtD
Ephedrine—Dyspnoea—Mitoxantrone—breast cancer	0.000168	0.00115	CcSEcCtD
Ephedrine—BCHE—endocrine gland—breast cancer	0.000168	0.0224	CbGeAlD
Ephedrine—Headache—Tamoxifen—breast cancer	0.000168	0.00115	CcSEcCtD
Ephedrine—Palpitations—Paclitaxel—breast cancer	0.000167	0.00114	CcSEcCtD
Ephedrine—Vomiting—Melphalan—breast cancer	0.000167	0.00114	CcSEcCtD
Ephedrine—Insomnia—Gemcitabine—breast cancer	0.000166	0.00114	CcSEcCtD
Ephedrine—Dyspepsia—Mitoxantrone—breast cancer	0.000166	0.00114	CcSEcCtD
Ephedrine—Dyspepsia—Irinotecan—breast cancer	0.000166	0.00114	CcSEcCtD
Ephedrine—Rash—Melphalan—breast cancer	0.000165	0.00113	CcSEcCtD
Ephedrine—Dermatitis—Melphalan—breast cancer	0.000165	0.00113	CcSEcCtD
Ephedrine—Asthenia—Vinorelbine—breast cancer	0.000164	0.00113	CcSEcCtD
Ephedrine—Decreased appetite—Irinotecan—breast cancer	0.000164	0.00113	CcSEcCtD
Ephedrine—Decreased appetite—Mitoxantrone—breast cancer	0.000164	0.00113	CcSEcCtD
Ephedrine—Arrhythmia—Docetaxel—breast cancer	0.000164	0.00113	CcSEcCtD
Ephedrine—Dyspnoea—Gemcitabine—breast cancer	0.000164	0.00112	CcSEcCtD
Ephedrine—Nausea—Vinblastine—breast cancer	0.000164	0.00112	CcSEcCtD
Ephedrine—Insomnia—Fluorouracil—breast cancer	0.000164	0.00112	CcSEcCtD
Ephedrine—Hypertension—Paclitaxel—breast cancer	0.000163	0.00112	CcSEcCtD
Ephedrine—Vomiting—Goserelin—breast cancer	0.000162	0.00111	CcSEcCtD
Ephedrine—Pain—Irinotecan—breast cancer	0.000161	0.00111	CcSEcCtD
Ephedrine—Pain—Mitoxantrone—breast cancer	0.000161	0.00111	CcSEcCtD
Ephedrine—Dyspnoea—Fluorouracil—breast cancer	0.000161	0.00111	CcSEcCtD
Ephedrine—Rash—Goserelin—breast cancer	0.000161	0.00111	CcSEcCtD
Ephedrine—Dermatitis—Goserelin—breast cancer	0.000161	0.0011	CcSEcCtD
Ephedrine—Chest pain—Paclitaxel—breast cancer	0.000161	0.0011	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP1A1—breast cancer	0.00016	0.0352	CrCbGaD
Ephedrine—Headache—Goserelin—breast cancer	0.00016	0.0011	CcSEcCtD
Ephedrine—Anxiety—Paclitaxel—breast cancer	0.00016	0.0011	CcSEcCtD
Ephedrine—Decreased appetite—Gemcitabine—breast cancer	0.00016	0.0011	CcSEcCtD
Ephedrine—Dyspepsia—Fluorouracil—breast cancer	0.000159	0.00109	CcSEcCtD
Ephedrine—Nausea—Tamoxifen—breast cancer	0.000159	0.00109	CcSEcCtD
Ephedrine—Arrhythmia—Capecitabine—breast cancer	0.000159	0.00109	CcSEcCtD
Ephedrine—Pain—Gemcitabine—breast cancer	0.000157	0.00108	CcSEcCtD
Ephedrine—Decreased appetite—Fluorouracil—breast cancer	0.000157	0.00108	CcSEcCtD
Ephedrine—Asthenia—Thiotepa—breast cancer	0.000157	0.00108	CcSEcCtD
Ephedrine—Nausea—Melphalan—breast cancer	0.000156	0.00107	CcSEcCtD
Ephedrine—Feeling abnormal—Irinotecan—breast cancer	0.000156	0.00107	CcSEcCtD
Ephedrine—Feeling abnormal—Mitoxantrone—breast cancer	0.000156	0.00107	CcSEcCtD
Ephedrine—Confusional state—Paclitaxel—breast cancer	0.000155	0.00106	CcSEcCtD
Ephedrine—Dysuria—Methotrexate—breast cancer	0.000155	0.00106	CcSEcCtD
Ephedrine—Pain—Fluorouracil—breast cancer	0.000155	0.00106	CcSEcCtD
Ephedrine—Muscle spasms—Docetaxel—breast cancer	0.000154	0.00105	CcSEcCtD
Ephedrine—Nausea—Goserelin—breast cancer	0.000152	0.00104	CcSEcCtD
Ephedrine—Feeling abnormal—Gemcitabine—breast cancer	0.000152	0.00104	CcSEcCtD
Ephedrine—Dizziness—Vinorelbine—breast cancer	0.000151	0.00104	CcSEcCtD
Ephedrine—Angina pectoris—Epirubicin—breast cancer	0.000151	0.00103	CcSEcCtD
Ephedrine—Tachycardia—Paclitaxel—breast cancer	0.00015	0.00103	CcSEcCtD
Ephedrine—Body temperature increased—Mitoxantrone—breast cancer	0.000149	0.00102	CcSEcCtD
Ephedrine—Body temperature increased—Irinotecan—breast cancer	0.000149	0.00102	CcSEcCtD
Ephedrine—Feeling abnormal—Fluorouracil—breast cancer	0.000149	0.00102	CcSEcCtD
Ephedrine—Muscle spasms—Capecitabine—breast cancer	0.000149	0.00102	CcSEcCtD
Ephedrine—Hyperhidrosis—Paclitaxel—breast cancer	0.000149	0.00102	CcSEcCtD
Ephedrine—Anorexia—Paclitaxel—breast cancer	0.000147	0.00101	CcSEcCtD
Ephedrine—Vomiting—Vinorelbine—breast cancer	0.000146	0.000998	CcSEcCtD
Ephedrine—Body temperature increased—Gemcitabine—breast cancer	0.000145	0.000997	CcSEcCtD
Ephedrine—Tremor—Capecitabine—breast cancer	0.000145	0.000995	CcSEcCtD
Ephedrine—Dysuria—Epirubicin—breast cancer	0.000145	0.000993	CcSEcCtD
Ephedrine—Dizziness—Thiotepa—breast cancer	0.000145	0.000992	CcSEcCtD
Ephedrine—Rash—Vinorelbine—breast cancer	0.000144	0.00099	CcSEcCtD
Ephedrine—Dermatitis—Vinorelbine—breast cancer	0.000144	0.000989	CcSEcCtD
Ephedrine—Headache—Vinorelbine—breast cancer	0.000143	0.000984	CcSEcCtD
Ephedrine—Body temperature increased—Fluorouracil—breast cancer	0.000143	0.00098	CcSEcCtD
Ephedrine—Sweating—Methotrexate—breast cancer	0.000141	0.00097	CcSEcCtD
Ephedrine—Palpitations—Docetaxel—breast cancer	0.000141	0.000969	CcSEcCtD
Ephedrine—SLC6A2—lymph node—breast cancer	0.00014	0.0188	CbGeAlD
Ephedrine—Angina pectoris—Doxorubicin—breast cancer	0.000139	0.000957	CcSEcCtD
Ephedrine—Insomnia—Paclitaxel—breast cancer	0.000139	0.000955	CcSEcCtD
Ephedrine—Vertigo—Capecitabine—breast cancer	0.000139	0.000954	CcSEcCtD
Ephedrine—Vomiting—Thiotepa—breast cancer	0.000139	0.000953	CcSEcCtD
Ephedrine—Hypertension—Docetaxel—breast cancer	0.000138	0.000947	CcSEcCtD
Ephedrine—Rash—Thiotepa—breast cancer	0.000138	0.000945	CcSEcCtD
Ephedrine—Dermatitis—Thiotepa—breast cancer	0.000138	0.000945	CcSEcCtD
Ephedrine—Dyspnoea—Paclitaxel—breast cancer	0.000137	0.000942	CcSEcCtD
Ephedrine—Headache—Thiotepa—breast cancer	0.000137	0.000939	CcSEcCtD
Ephedrine—Palpitations—Capecitabine—breast cancer	0.000137	0.000938	CcSEcCtD
Ephedrine—Chest pain—Docetaxel—breast cancer	0.000136	0.000934	CcSEcCtD
Ephedrine—Nausea—Vinorelbine—breast cancer	0.000136	0.000933	CcSEcCtD
Ephedrine—Dyspepsia—Paclitaxel—breast cancer	0.000136	0.00093	CcSEcCtD
Ephedrine—Asthenia—Irinotecan—breast cancer	0.000135	0.000929	CcSEcCtD
Ephedrine—Asthenia—Mitoxantrone—breast cancer	0.000135	0.000929	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—breast cancer	0.000134	0.000919	CcSEcCtD
Ephedrine—Decreased appetite—Paclitaxel—breast cancer	0.000134	0.000918	CcSEcCtD
Ephedrine—Hypertension—Capecitabine—breast cancer	0.000134	0.000917	CcSEcCtD
Ephedrine—Sweating—Epirubicin—breast cancer	0.000132	0.000908	CcSEcCtD
Ephedrine—Asthenia—Gemcitabine—breast cancer	0.000132	0.000905	CcSEcCtD
Ephedrine—Chest pain—Capecitabine—breast cancer	0.000132	0.000904	CcSEcCtD
Ephedrine—Pain—Paclitaxel—breast cancer	0.000132	0.000903	CcSEcCtD
Ephedrine—Confusional state—Docetaxel—breast cancer	0.000132	0.000903	CcSEcCtD
Ephedrine—Anxiety—Capecitabine—breast cancer	0.000131	0.000901	CcSEcCtD
Ephedrine—Nausea—Thiotepa—breast cancer	0.00013	0.000891	CcSEcCtD
Ephedrine—Confusional state—Capecitabine—breast cancer	0.000127	0.000874	CcSEcCtD
Ephedrine—Tachycardia—Docetaxel—breast cancer	0.000127	0.000874	CcSEcCtD
Ephedrine—Feeling abnormal—Paclitaxel—breast cancer	0.000127	0.00087	CcSEcCtD
Ephedrine—Bradycardia—Epirubicin—breast cancer	0.000126	0.000865	CcSEcCtD
Ephedrine—Dizziness—Irinotecan—breast cancer	0.000125	0.000856	CcSEcCtD
Ephedrine—Anorexia—Docetaxel—breast cancer	0.000124	0.000853	CcSEcCtD
Ephedrine—Phentermine—CYP2D6—breast cancer	0.000124	0.0272	CrCbGaD
Ephedrine—Tachycardia—Capecitabine—breast cancer	0.000123	0.000846	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—breast cancer	0.000122	0.00084	CcSEcCtD
Ephedrine—Hyperhidrosis—Capecitabine—breast cancer	0.000122	0.000838	CcSEcCtD
Ephedrine—Body temperature increased—Paclitaxel—breast cancer	0.000122	0.000835	CcSEcCtD
Ephedrine—Anorexia—Capecitabine—breast cancer	0.00012	0.000826	CcSEcCtD
Ephedrine—Vomiting—Irinotecan—breast cancer	0.00012	0.000823	CcSEcCtD
Ephedrine—Vomiting—Mitoxantrone—breast cancer	0.00012	0.000823	CcSEcCtD
Ephedrine—Dizziness—Fluorouracil—breast cancer	0.00012	0.00082	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP2D6—breast cancer	0.000119	0.0262	CrCbGaD
Ephedrine—Rash—Mitoxantrone—breast cancer	0.000119	0.000816	CcSEcCtD
Ephedrine—Rash—Irinotecan—breast cancer	0.000119	0.000816	CcSEcCtD
Ephedrine—Dermatitis—Irinotecan—breast cancer	0.000119	0.000816	CcSEcCtD
Ephedrine—Dermatitis—Mitoxantrone—breast cancer	0.000119	0.000816	CcSEcCtD
Ephedrine—Headache—Irinotecan—breast cancer	0.000118	0.000811	CcSEcCtD
Ephedrine—Headache—Mitoxantrone—breast cancer	0.000118	0.000811	CcSEcCtD
Ephedrine—Dextroamphetamine—CYP2D6—breast cancer	0.000118	0.0259	CrCbGaD
Ephedrine—Insomnia—Docetaxel—breast cancer	0.000118	0.00081	CcSEcCtD
Ephedrine—Pseudoephedrine—CYP2D6—breast cancer	0.000117	0.0257	CrCbGaD
Ephedrine—Vomiting—Gemcitabine—breast cancer	0.000117	0.000802	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—breast cancer	0.000117	0.0008	CcSEcCtD
Ephedrine—Dyspnoea—Docetaxel—breast cancer	0.000116	0.000798	CcSEcCtD
Ephedrine—BCHE—lymph node—breast cancer	0.000116	0.0155	CbGeAlD
Ephedrine—Rash—Gemcitabine—breast cancer	0.000116	0.000795	CcSEcCtD
Ephedrine—Dermatitis—Gemcitabine—breast cancer	0.000116	0.000795	CcSEcCtD
Ephedrine—Headache—Gemcitabine—breast cancer	0.000115	0.00079	CcSEcCtD
Ephedrine—Vomiting—Fluorouracil—breast cancer	0.000115	0.000789	CcSEcCtD
Ephedrine—Dyspepsia—Docetaxel—breast cancer	0.000115	0.000788	CcSEcCtD
Ephedrine—Selegiline—CYP2D6—breast cancer	0.000115	0.0251	CrCbGaD
Ephedrine—Insomnia—Capecitabine—breast cancer	0.000114	0.000784	CcSEcCtD
Ephedrine—Rash—Fluorouracil—breast cancer	0.000114	0.000782	CcSEcCtD
Ephedrine—Dermatitis—Fluorouracil—breast cancer	0.000114	0.000781	CcSEcCtD
Ephedrine—Decreased appetite—Docetaxel—breast cancer	0.000113	0.000778	CcSEcCtD
Ephedrine—Headache—Fluorouracil—breast cancer	0.000113	0.000777	CcSEcCtD
Ephedrine—Dyspnoea—Capecitabine—breast cancer	0.000113	0.000773	CcSEcCtD
Ephedrine—Nausea—Mitoxantrone—breast cancer	0.000112	0.000769	CcSEcCtD
Ephedrine—Nausea—Irinotecan—breast cancer	0.000112	0.000769	CcSEcCtD
Ephedrine—Pain—Docetaxel—breast cancer	0.000112	0.000765	CcSEcCtD
Ephedrine—Dyspepsia—Capecitabine—breast cancer	0.000111	0.000763	CcSEcCtD
Ephedrine—Arrhythmia—Epirubicin—breast cancer	0.000111	0.000759	CcSEcCtD
Ephedrine—Asthenia—Paclitaxel—breast cancer	0.00011	0.000758	CcSEcCtD
Ephedrine—Decreased appetite—Capecitabine—breast cancer	0.00011	0.000753	CcSEcCtD
Ephedrine—Nausea—Gemcitabine—breast cancer	0.000109	0.000749	CcSEcCtD
Ephedrine—Pain—Capecitabine—breast cancer	0.000108	0.000741	CcSEcCtD
Ephedrine—Feeling abnormal—Docetaxel—breast cancer	0.000108	0.000738	CcSEcCtD
Ephedrine—Nausea—Fluorouracil—breast cancer	0.000107	0.000737	CcSEcCtD
Ephedrine—Tension—Epirubicin—breast cancer	0.000106	0.000726	CcSEcCtD
Ephedrine—Nervousness—Epirubicin—breast cancer	0.000105	0.000718	CcSEcCtD
Ephedrine—Feeling abnormal—Capecitabine—breast cancer	0.000104	0.000714	CcSEcCtD
Ephedrine—Muscle spasms—Epirubicin—breast cancer	0.000104	0.000711	CcSEcCtD
Ephedrine—Vertigo—Methotrexate—breast cancer	0.000104	0.00071	CcSEcCtD
Ephedrine—Body temperature increased—Docetaxel—breast cancer	0.000103	0.000708	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—breast cancer	0.000102	0.000702	CcSEcCtD
Ephedrine—Benzyl alcohol—CYP3A4—breast cancer	0.000102	0.0225	CrCbGaD
Ephedrine—Dizziness—Paclitaxel—breast cancer	0.000102	0.000698	CcSEcCtD
Ephedrine—Body temperature increased—Capecitabine—breast cancer	9.99e-05	0.000685	CcSEcCtD
Ephedrine—Agitation—Epirubicin—breast cancer	9.91e-05	0.00068	CcSEcCtD
Ephedrine—Selegiline—CYP3A4—breast cancer	9.83e-05	0.0216	CrCbGaD
Ephedrine—Chest pain—Methotrexate—breast cancer	9.81e-05	0.000673	CcSEcCtD
Ephedrine—Tension—Doxorubicin—breast cancer	9.79e-05	0.000672	CcSEcCtD
Ephedrine—Vomiting—Paclitaxel—breast cancer	9.79e-05	0.000671	CcSEcCtD
Ephedrine—Rash—Paclitaxel—breast cancer	9.71e-05	0.000666	CcSEcCtD
Ephedrine—Dermatitis—Paclitaxel—breast cancer	9.7e-05	0.000665	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—breast cancer	9.69e-05	0.000665	CcSEcCtD
Ephedrine—Vertigo—Epirubicin—breast cancer	9.69e-05	0.000665	CcSEcCtD
Ephedrine—Headache—Paclitaxel—breast cancer	9.64e-05	0.000662	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—breast cancer	9.59e-05	0.000658	CcSEcCtD
Ephedrine—Palpitations—Epirubicin—breast cancer	9.53e-05	0.000654	CcSEcCtD
Ephedrine—Amphetamine—CYP2D6—breast cancer	9.52e-05	0.0209	CrCbGaD
Ephedrine—Confusional state—Methotrexate—breast cancer	9.48e-05	0.000651	CcSEcCtD
Ephedrine—Asthenia—Docetaxel—breast cancer	9.36e-05	0.000642	CcSEcCtD
Ephedrine—Hypertension—Epirubicin—breast cancer	9.31e-05	0.000639	CcSEcCtD
Ephedrine—Chest pain—Epirubicin—breast cancer	9.18e-05	0.00063	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—breast cancer	9.17e-05	0.000629	CcSEcCtD
Ephedrine—Anxiety—Epirubicin—breast cancer	9.15e-05	0.000628	CcSEcCtD
Ephedrine—Nausea—Paclitaxel—breast cancer	9.14e-05	0.000627	CcSEcCtD
Ephedrine—Hyperhidrosis—Methotrexate—breast cancer	9.09e-05	0.000624	CcSEcCtD
Ephedrine—Asthenia—Capecitabine—breast cancer	9.06e-05	0.000622	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—breast cancer	8.96e-05	0.000615	CcSEcCtD
Ephedrine—Anorexia—Methotrexate—breast cancer	8.96e-05	0.000615	CcSEcCtD
Ephedrine—Confusional state—Epirubicin—breast cancer	8.87e-05	0.000609	CcSEcCtD
Ephedrine—Methamphetamine—CYP2D6—breast cancer	8.82e-05	0.0194	CrCbGaD
Ephedrine—Palpitations—Doxorubicin—breast cancer	8.82e-05	0.000605	CcSEcCtD
Ephedrine—Atomoxetine—CYP2D6—breast cancer	8.68e-05	0.019	CrCbGaD
Ephedrine—Dizziness—Docetaxel—breast cancer	8.63e-05	0.000592	CcSEcCtD
Ephedrine—Hypertension—Doxorubicin—breast cancer	8.61e-05	0.000591	CcSEcCtD
Ephedrine—Tachycardia—Epirubicin—breast cancer	8.59e-05	0.000589	CcSEcCtD
Ephedrine—Hyperhidrosis—Epirubicin—breast cancer	8.51e-05	0.000584	CcSEcCtD
Ephedrine—Insomnia—Methotrexate—breast cancer	8.51e-05	0.000584	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—breast cancer	8.49e-05	0.000583	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—breast cancer	8.47e-05	0.000581	CcSEcCtD
Ephedrine—Anorexia—Epirubicin—breast cancer	8.39e-05	0.000575	CcSEcCtD
Ephedrine—Dyspnoea—Methotrexate—breast cancer	8.38e-05	0.000575	CcSEcCtD
Ephedrine—Dizziness—Capecitabine—breast cancer	8.35e-05	0.000573	CcSEcCtD
Ephedrine—Vomiting—Docetaxel—breast cancer	8.3e-05	0.000569	CcSEcCtD
Ephedrine—Dyspepsia—Methotrexate—breast cancer	8.28e-05	0.000568	CcSEcCtD
Ephedrine—Rash—Docetaxel—breast cancer	8.23e-05	0.000564	CcSEcCtD
Ephedrine—Dermatitis—Docetaxel—breast cancer	8.22e-05	0.000564	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—breast cancer	8.21e-05	0.000563	CcSEcCtD
Ephedrine—Selegiline—ABCB1—breast cancer	8.18e-05	0.0179	CrCbGaD
Ephedrine—Decreased appetite—Methotrexate—breast cancer	8.17e-05	0.000561	CcSEcCtD
Ephedrine—Headache—Docetaxel—breast cancer	8.17e-05	0.000561	CcSEcCtD
Ephedrine—Pain—Methotrexate—breast cancer	8.04e-05	0.000552	CcSEcCtD
Ephedrine—Vomiting—Capecitabine—breast cancer	8.03e-05	0.000551	CcSEcCtD
Ephedrine—Rash—Capecitabine—breast cancer	7.97e-05	0.000546	CcSEcCtD
Ephedrine—Insomnia—Epirubicin—breast cancer	7.96e-05	0.000546	CcSEcCtD
Ephedrine—Dermatitis—Capecitabine—breast cancer	7.96e-05	0.000546	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—breast cancer	7.95e-05	0.000545	CcSEcCtD
Ephedrine—Headache—Capecitabine—breast cancer	7.91e-05	0.000543	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—breast cancer	7.87e-05	0.00054	CcSEcCtD
Ephedrine—Dyspnoea—Epirubicin—breast cancer	7.85e-05	0.000538	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—breast cancer	7.76e-05	0.000532	CcSEcCtD
Ephedrine—Nausea—Docetaxel—breast cancer	7.75e-05	0.000532	CcSEcCtD
Ephedrine—Feeling abnormal—Methotrexate—breast cancer	7.75e-05	0.000532	CcSEcCtD
Ephedrine—Dyspepsia—Epirubicin—breast cancer	7.75e-05	0.000531	CcSEcCtD
Ephedrine—Decreased appetite—Epirubicin—breast cancer	7.65e-05	0.000525	CcSEcCtD
Ephedrine—Pain—Epirubicin—breast cancer	7.53e-05	0.000516	CcSEcCtD
Ephedrine—Nausea—Capecitabine—breast cancer	7.5e-05	0.000515	CcSEcCtD
Ephedrine—Atomoxetine—CYP3A4—breast cancer	7.45e-05	0.0163	CrCbGaD
Ephedrine—Body temperature increased—Methotrexate—breast cancer	7.43e-05	0.00051	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—breast cancer	7.37e-05	0.000505	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—breast cancer	7.26e-05	0.000498	CcSEcCtD
Ephedrine—Feeling abnormal—Epirubicin—breast cancer	7.25e-05	0.000498	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—breast cancer	7.17e-05	0.000492	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—breast cancer	7.08e-05	0.000486	CcSEcCtD
Ephedrine—Pain—Doxorubicin—breast cancer	6.96e-05	0.000478	CcSEcCtD
Ephedrine—Body temperature increased—Epirubicin—breast cancer	6.96e-05	0.000477	CcSEcCtD
Ephedrine—Asthenia—Methotrexate—breast cancer	6.75e-05	0.000463	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—breast cancer	6.71e-05	0.00046	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—breast cancer	6.44e-05	0.000442	CcSEcCtD
Ephedrine—Asthenia—Epirubicin—breast cancer	6.31e-05	0.000433	CcSEcCtD
Ephedrine—Dizziness—Methotrexate—breast cancer	6.22e-05	0.000427	CcSEcCtD
Ephedrine—Vomiting—Methotrexate—breast cancer	5.98e-05	0.00041	CcSEcCtD
Ephedrine—Rash—Methotrexate—breast cancer	5.93e-05	0.000407	CcSEcCtD
Ephedrine—Dermatitis—Methotrexate—breast cancer	5.92e-05	0.000406	CcSEcCtD
Ephedrine—Headache—Methotrexate—breast cancer	5.89e-05	0.000404	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—breast cancer	5.84e-05	0.000401	CcSEcCtD
Ephedrine—Dizziness—Epirubicin—breast cancer	5.82e-05	0.000399	CcSEcCtD
Ephedrine—Vomiting—Epirubicin—breast cancer	5.6e-05	0.000384	CcSEcCtD
Ephedrine—Nausea—Methotrexate—breast cancer	5.59e-05	0.000383	CcSEcCtD
Ephedrine—Rash—Epirubicin—breast cancer	5.55e-05	0.000381	CcSEcCtD
Ephedrine—Dermatitis—Epirubicin—breast cancer	5.54e-05	0.00038	CcSEcCtD
Ephedrine—Headache—Epirubicin—breast cancer	5.51e-05	0.000378	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—breast cancer	5.38e-05	0.000369	CcSEcCtD
Ephedrine—Nausea—Epirubicin—breast cancer	5.23e-05	0.000359	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—breast cancer	5.18e-05	0.000355	CcSEcCtD
Ephedrine—Rash—Doxorubicin—breast cancer	5.13e-05	0.000352	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—breast cancer	5.13e-05	0.000352	CcSEcCtD
Ephedrine—Headache—Doxorubicin—breast cancer	5.1e-05	0.00035	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—breast cancer	4.84e-05	0.000332	CcSEcCtD
Ephedrine—BCHE—Metabolism—NCOR1—breast cancer	1.09e-05	0.000132	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PLA2G4A—breast cancer	1.09e-05	0.000132	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GSTM1—breast cancer	1.09e-05	0.000132	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PAK1—breast cancer	1.09e-05	0.000131	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—MTHFR—breast cancer	1.08e-05	0.000131	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL2—breast cancer	1.08e-05	0.00013	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR2—breast cancer	1.08e-05	0.00013	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTNNB1—breast cancer	1.07e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TCF7L2—breast cancer	1.07e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTHLH—breast cancer	1.07e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BMP2—breast cancer	1.07e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT2—breast cancer	1.06e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—breast cancer	1.06e-05	0.000128	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GPX1—breast cancer	1.05e-05	0.000127	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CYP1A1—breast cancer	1.04e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EDNRB—breast cancer	1.03e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH2—breast cancer	1.03e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HSP90AA1—breast cancer	1.03e-05	0.000125	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ERCC2—breast cancer	1.03e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PGR—breast cancer	1.02e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—breast cancer	1.02e-05	0.000124	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—THBS1—breast cancer	1.02e-05	0.000123	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PRL—breast cancer	1e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGTR1—breast cancer	1e-05	0.000121	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CAV1—breast cancer	1e-05	0.000121	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ADAM10—breast cancer	9.88e-06	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STK11—breast cancer	9.88e-06	0.000119	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLG—breast cancer	9.77e-06	0.000118	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FLT1—breast cancer	9.71e-06	0.000117	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—MTHFR—breast cancer	9.67e-06	0.000117	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SQSTM1—breast cancer	9.67e-06	0.000117	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF3—breast cancer	9.67e-06	0.000117	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT2—breast cancer	9.66e-06	0.000117	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—breast cancer	9.62e-06	0.000116	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF10—breast cancer	9.61e-06	0.000116	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.55e-06	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAG1—breast cancer	9.54e-06	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH3—breast cancer	9.5e-06	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PARP1—breast cancer	9.5e-06	0.000115	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CALCA—breast cancer	9.39e-06	0.000113	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—breast cancer	9.28e-06	0.000112	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RPS6—breast cancer	9.27e-06	0.000112	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PDGFA—breast cancer	9.27e-06	0.000112	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF4—breast cancer	9.2e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL12—breast cancer	9.17e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCR4—breast cancer	9.17e-06	0.000111	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFBR2—breast cancer	9.14e-06	0.00011	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—breast cancer	9.11e-06	0.00011	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PAK1—breast cancer	9e-06	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ITPR1—breast cancer	8.99e-06	0.000109	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB4—breast cancer	8.93e-06	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT5A—breast cancer	8.93e-06	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP3—breast cancer	8.93e-06	0.000108	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CAV1—breast cancer	8.92e-06	0.000108	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—breast cancer	8.91e-06	0.000108	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TCF7L2—breast cancer	8.84e-06	0.000107	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT2—breast cancer	8.8e-06	0.000106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—breast cancer	8.73e-06	0.000106	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SMAD4—breast cancer	8.65e-06	0.000105	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1R—breast cancer	8.6e-06	0.000104	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—breast cancer	8.56e-06	0.000103	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HSP90AA1—breast cancer	8.52e-06	0.000103	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH2—breast cancer	8.52e-06	0.000103	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.52e-06	0.000103	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—breast cancer	8.45e-06	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HES1—breast cancer	8.45e-06	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NCOR1—breast cancer	8.4e-06	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PLA2G4A—breast cancer	8.4e-06	0.000102	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGF1—breast cancer	8.31e-06	0.0001	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CSF2—breast cancer	8.31e-06	0.0001	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR1—breast cancer	8.29e-06	0.0001	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PRL—breast cancer	8.29e-06	0.0001	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—RAF1—breast cancer	8.29e-06	0.0001	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRG1—breast cancer	8.24e-06	9.97e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—H2AFX—breast cancer	8.19e-06	9.89e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—IL2—breast cancer	8.18e-06	9.89e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ADAM10—breast cancer	8.17e-06	9.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STK11—breast cancer	8.17e-06	9.88e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—E2F1—breast cancer	8.13e-06	9.82e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—breast cancer	8.12e-06	9.82e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—breast cancer	8.09e-06	9.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLG—breast cancer	8.08e-06	9.77e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—breast cancer	8.01e-06	9.68e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT2—breast cancer	7.99e-06	9.66e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF10—breast cancer	7.95e-06	9.61e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—ALB—breast cancer	7.9e-06	9.55e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SPP1—breast cancer	7.81e-06	9.44e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—breast cancer	7.77e-06	9.4e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB3—breast cancer	7.72e-06	9.34e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR2—breast cancer	7.71e-06	9.32e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—breast cancer	7.68e-06	9.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PDGFA—breast cancer	7.67e-06	9.27e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFBR2—breast cancer	7.56e-06	9.14e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—NOS3—breast cancer	7.56e-06	9.14e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ITPR1—breast cancer	7.44e-06	8.99e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL2—breast cancer	7.43e-06	8.98e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—breast cancer	7.4e-06	8.95e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT5A—breast cancer	7.39e-06	8.93e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB4—breast cancer	7.39e-06	8.93e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP3—breast cancer	7.39e-06	8.93e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—breast cancer	7.37e-06	8.91e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FGFR1—breast cancer	7.19e-06	8.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMAD4—breast cancer	7.16e-06	8.65e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—breast cancer	7.14e-06	8.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1R—breast cancer	7.11e-06	8.6e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—breast cancer	7.08e-06	8.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—breast cancer	7.08e-06	8.56e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—ALB—breast cancer	7.05e-06	8.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HES1—breast cancer	6.99e-06	8.45e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—breast cancer	6.98e-06	8.43e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NCOR1—breast cancer	6.95e-06	8.4e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PLA2G4A—breast cancer	6.95e-06	8.4e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—breast cancer	6.91e-06	8.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—LEP—breast cancer	6.91e-06	8.35e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CSF2—breast cancer	6.87e-06	8.3e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGF1—breast cancer	6.87e-06	8.3e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—RAF1—breast cancer	6.85e-06	8.28e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CAV1—breast cancer	6.85e-06	8.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRG1—breast cancer	6.82e-06	8.24e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—H2AFX—breast cancer	6.77e-06	8.18e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KDR—breast cancer	6.77e-06	8.18e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IL2—breast cancer	6.77e-06	8.18e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—NOS3—breast cancer	6.74e-06	8.15e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—E2F1—breast cancer	6.72e-06	8.13e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—breast cancer	6.69e-06	8.09e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ESR1—breast cancer	6.6e-06	7.98e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—FN1—breast cancer	6.52e-06	7.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SPP1—breast cancer	6.46e-06	7.81e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NFKBIA—breast cancer	6.44e-06	7.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—breast cancer	6.43e-06	7.77e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB3—breast cancer	6.39e-06	7.72e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR2—breast cancer	6.38e-06	7.71e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH1—breast cancer	6.38e-06	7.71e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APC—breast cancer	6.24e-06	7.54e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—breast cancer	6.24e-06	7.54e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KIT—breast cancer	6.24e-06	7.54e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—breast cancer	6.23e-06	7.52e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—breast cancer	6.17e-06	7.46e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGF—breast cancer	6.17e-06	7.45e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL2—breast cancer	6.15e-06	7.43e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—breast cancer	6.12e-06	7.4e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—breast cancer	6.03e-06	7.29e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—MAPK3—breast cancer	5.97e-06	7.22e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FGFR1—breast cancer	5.95e-06	7.19e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—BRAF—breast cancer	5.86e-06	7.09e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—breast cancer	5.86e-06	7.08e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—LEP—breast cancer	5.72e-06	6.91e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IGF1—breast cancer	5.71e-06	6.9e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT2—breast cancer	5.71e-06	6.9e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—breast cancer	5.68e-06	6.87e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CAV1—breast cancer	5.66e-06	6.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KDR—breast cancer	5.6e-06	6.77e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—breast cancer	5.48e-06	6.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ESR1—breast cancer	5.46e-06	6.6e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	5.43e-06	6.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SERPINE1—breast cancer	5.42e-06	6.56e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—FN1—breast cancer	5.39e-06	6.52e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—breast cancer	5.38e-06	6.5e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—breast cancer	5.37e-06	6.49e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NFKBIA—breast cancer	5.33e-06	6.44e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH1—breast cancer	5.28e-06	6.38e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOS3—breast cancer	5.18e-06	6.26e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—breast cancer	5.16e-06	6.24e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KIT—breast cancer	5.16e-06	6.24e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APC—breast cancer	5.16e-06	6.24e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGF—breast cancer	5.1e-06	6.16e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—MAPK3—breast cancer	4.94e-06	5.97e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	4.93e-06	5.96e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MDM2—breast cancer	4.91e-06	5.94e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RAF1—breast cancer	4.9e-06	5.92e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—RELA—breast cancer	4.87e-06	5.89e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—BRAF—breast cancer	4.85e-06	5.86e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—ERBB2—breast cancer	4.84e-06	5.85e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MTOR—breast cancer	4.78e-06	5.78e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—breast cancer	4.78e-06	5.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IGF1—breast cancer	4.72e-06	5.71e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT2—breast cancer	4.72e-06	5.71e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—breast cancer	4.7e-06	5.68e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—breast cancer	4.59e-06	5.55e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HRAS—breast cancer	4.56e-06	5.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—breast cancer	4.54e-06	5.48e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—breast cancer	4.49e-06	5.43e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SERPINE1—breast cancer	4.49e-06	5.42e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1B—breast cancer	4.49e-06	5.42e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—breast cancer	4.44e-06	5.37e-05	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—breast cancer	4.44e-06	5.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—breast cancer	4.4e-06	5.31e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL2—breast cancer	4.39e-06	5.31e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—IL6—breast cancer	4.37e-06	5.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOS3—breast cancer	4.28e-06	5.18e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—breast cancer	4.28e-06	5.17e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JUN—breast cancer	4.27e-06	5.16e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—breast cancer	4.25e-06	5.14e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CTNNB1—breast cancer	4.24e-06	5.12e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—breast cancer	4.15e-06	5.02e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CDKN1A—breast cancer	4.14e-06	5e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—breast cancer	4.13e-06	4.99e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—breast cancer	4.08e-06	4.93e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MDM2—breast cancer	4.06e-06	4.91e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RAF1—breast cancer	4.05e-06	4.89e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK8—breast cancer	4.04e-06	4.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—RELA—breast cancer	4.03e-06	4.87e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—breast cancer	4.03e-06	4.87e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ERBB2—breast cancer	4.01e-06	4.84e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MTOR—breast cancer	3.95e-06	4.78e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—breast cancer	3.95e-06	4.78e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SRC—breast cancer	3.83e-06	4.63e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—breast cancer	3.8e-06	4.59e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—breast cancer	3.79e-06	4.59e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HRAS—breast cancer	3.77e-06	4.56e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—breast cancer	3.73e-06	4.51e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1B—breast cancer	3.71e-06	4.48e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—breast cancer	3.69e-06	4.46e-05	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—breast cancer	3.67e-06	4.44e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—breast cancer	3.64e-06	4.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL2—breast cancer	3.63e-06	4.39e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IL6—breast cancer	3.61e-06	4.37e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—breast cancer	3.54e-06	4.28e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JUN—breast cancer	3.53e-06	4.27e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MAPK3—breast cancer	3.53e-06	4.27e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNB1—breast cancer	3.5e-06	4.24e-05	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—breast cancer	3.48e-06	4.2e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—breast cancer	3.44e-06	4.15e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—breast cancer	3.43e-06	4.15e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CDKN1A—breast cancer	3.42e-06	4.14e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—breast cancer	3.42e-06	4.14e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—breast cancer	3.42e-06	4.13e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—breast cancer	3.36e-06	4.06e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	3.34e-06	4.04e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	3.33e-06	4.03e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—breast cancer	3.17e-06	3.83e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SRC—breast cancer	3.17e-06	3.83e-05	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—breast cancer	3.1e-06	3.75e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	3.09e-06	3.73e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—breast cancer	3.05e-06	3.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	2.92e-06	3.53e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	2.91e-06	3.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—breast cancer	2.84e-06	3.43e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	2.83e-06	3.42e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—breast cancer	2.82e-06	3.41e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—breast cancer	2.78e-06	3.36e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HRAS—breast cancer	2.7e-06	3.26e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—breast cancer	2.62e-06	3.17e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IL6—breast cancer	2.58e-06	3.12e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	2.41e-06	2.91e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—breast cancer	2.38e-06	2.88e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—breast cancer	2.33e-06	2.82e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRAS—breast cancer	2.23e-06	2.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IL6—breast cancer	2.13e-06	2.58e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—breast cancer	1.97e-06	2.38e-05	CbGpPWpGaD
